InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Cini John K., Directeur Scientifique. Insider active across 1 company, notably Sonnet BioTherapeutics Holdings, Inc.. Cumulatively, 7 reports have been logged. Activity tracked since 25 May 2021. The latest transaction was filed on 25 May 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
12,000 sharesCommon StockSEC:0001641172-25-019778:0
1,888 sharesCommon StockSEC:0001493152-24-048952:0
18,551 sharesCommon StockSEC:0001493152-23-005465:0
18,551 sharesCommon StockSEC:0001493152-22-036314:0
80,034 sharesCommon StockSEC:0001493152-22-009484:0
14,004 shares@ US$1.5150.0% of flowCommon StockSEC:0001493152-21-013205:0
14,004 shares@ US$1.5150.0% of flowCommon StockSEC:0001493152-21-013205
7 of 7 declarations
About Cini John K.
John K. Cini is the Chief Scientific Officer at Sonnet BioTherapeutics Holdings, Inc. He is responsible for leading the company's research and development initiatives. His scientific expertise is crucial for the development of new therapies and solutions in the biotechnology field.
